PET Imaging of Tumor Growth: Not as Easy as it Looks

Por Shields, Anthony F.
Publicado em 2012

The Role of DNA synthesis imaging in cancer in the era of targeted therapeutics

Por Nimmagadda, Sridhar, Shields, Anthony F.
Publicado em 2008

Characterizing Tumors Using Metabolic Imaging: PET Imaging of Cellular Proliferation and Steroid Receptors

Por Mankoff, David A, Dehdashti, Farrokh, Shields, Anthony F
Publicado em 2000

Simultaneous determination of 1-(2′-deoxy-2′-fluoro-β-D-arabinofuranosyl) uracil (FAU) and 1-(2′-deoxy-2′-fluoro- β-D-arabinofuranosyl 5-methyluracil (FMAU) in human plasma by liqu...

Por Wiegand, Richard, Wu, Jianmei, Shields, Anthony F., LoRusso, Patricia, Li, Jing
Publicado em 2012

Tracking cellular stress with labeled FMAU reflects changes in mitochondrial TK2

Por Tehrani, Omid S., Douglas, Kirk A., Lawhorn-Crews, Jawana M., Shields, Anthony F.
Publicado em 2008

PET Scans as a Predictive Marker of Survival in Advanced Colorectal Cancer

Por Choi, Minsig, Kollepara, Sri lakshmi S., Heilbrun, Lance K., Smith, Daryn, Shields, Anthony F., Philip, Philip A.
Publicado no Clin Colorectal Cancer (2014)

Using (18)F Fluorodeoxyglucose Positron Emission Tomography (FDG PET) to Monitor Clinical Outcomes in Patients Treated with Neoadjuvant Chemo-Radiotherapy for Locally Advanced Panc...

Por Choi, Minsig, Heilbrun, Lance K., Venkatramanamoorthy, Raghu, Lawhorn-Crews, Jawana M., Zalupski, Mark M., Shields, Anthony F.
Publicado em 2010

Cediranib in combination with various anticancer regimens: results of a phase I multi-cohort study

Por LoRusso, Patricia, Shields, Anthony F., Gadgeel, Shirish, Vaishampayan, Ulka, Guthrie, Tina, Puchalski, Thomas, Xu, John, Liu, Qi
Publicado em 2010

Impact on Patient Management of [(18)F]-Fluorodeoxyglucose-Positron Emission Tomography (PET) Used for Cancer Diagnosis: Analysis of Data From the National Oncologic PET Registry

Por Subramaniam, Rathan M., Shields, Anthony F., Sachedina, Archana, Hanna, Lucy, Duan, Fenghai, Siegel, Barry A., Hillner, Bruce E.
Publicado no Oncologist (2016)

Safety and Feasibility of Carboplatin and Paclitaxel followed by Fluoropyrimidine Analogs and Radiation as Adjuvant Therapy for Gastric Cancer

Por Mobayed, Mohammad, Heilbrun, Lance K., Shields, Anthony F., Washington, Tara, Venkatramanamoorthy, Raghu, Philip, Philip A., El-Rayes, Bassel F.
Publicado em 2009

Impact of Dedicated Brain PET on Intended Patient Management in Participants of the National Oncologic PET Registry

Por Hillner, Bruce E., Siegel, Barry A., Shields, Anthony F., Duan, Fenghai, Gareen, Ilana F., Hanna, Lucy, Coleman, R. Edward
Publicado em 2010

Glucocorticoid Receptor Status is a Principal Determinant of Variability in the Sensitivity of Non-Small Cell Lung Cancer Cells to Pemetrexed

Por Patki, Mugdha, Gadgeel, Shirish, Huang, Yanfang, McFall, Thomas, Shields, Anthony F., Matherly, Larry H., Bepler, Gerold, Ratnam, Manohar
Publicado em 2014

CA19-9 as a predictor of tumor response and survival in patients with advanced pancreatic cancer treated with gemcitabine based chemotherapy

Por HAMMAD, Nazik, HEILBRUN, Lance K, PHILIP, Philip A, SHIELDS, Anthony F, ZALUPSKI, Mark M, VENKATRAMANAMOORTHY, Raghu, EL-RAYES, Bassel F
Publicado em 2010

Squamous Cell Cancer of the Anal Canal in HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy: A Single Institution Experience

Por Hammad, Nazik, Heilbrun, Lance K., Gupta, Sachin, Tageja, Nishant, Philip, Philip A., Shields, Anthony F., Smith, Daryn, El-Rayes, Bassel F.
Publicado em 2011

Radiographic Parameters in Predicting Outcome of Patients with Hepatocellular Carcinoma Treated with Yttrium-90 Microsphere Radioembolization

Por Salem, Mohamed E., Jain, Nitin, Dyson, Gregory, Taylor, Stephanie, El-Refai, Sherif M., Choi, Minsig, Shields, Anthony F., Critchfield, Jeffery, Philip, Philip A.
Publicado em 2013

Clinicopathological analysis of primary epithelial appendiceal neoplasms

Por Gupta, Sachin, Parsa, Venkata, Adsay, Volkan, Heilbrun, Lance K., Smith, Daryn, Shields, Anthony F., Weaver, Donald, Philip, Philip A., El-Rayes, Bassel F.
Publicado em 2009

Carbohydrate Antigen 19-9 Is a Prognostic and Predictive Biomarker in Patients With Advanced Pancreatic Cancer Who Receive Gemcitabine-Containing Chemotherapy: A Pooled Analysis of...

Por Bauer, Todd M., El-Rayes, Bassel F., Li, Xiaobai, Hammad, Nazik, Philip, Philip A., Shields, Anthony F., Zalupski, Mark M., Bekaii-Saab, Tanios
Publicado no Cancer (2012)

Oxaliplatin-induced neurotoxicity is dependent on the organic cation transporter OCT2

Por Sprowl, Jason A., Ciarimboli, Giuliano, Lancaster, Cynthia S., Giovinazzo, Hugh, Gibson, Alice A., Du, Guoqing, Janke, Laura J., Cavaletti, Guido, Shields, Anthony F., Sparreboom, Alex
Publicado em 2013

Analysis and Reproducibility of 3′-Deoxy-3′-[(18)F]Fluorothymidine Positron Emission Tomography Imaging in Patients with Non -Small Cell Lung Cancer

Por Shields, Anthony F., Lawhorn-Crews, Jawana M., Briston, David A., Zalzala, Sajad, Gadgeel, Shirish, Douglas, Kirk A., Mangner, Thomas J., Heilbrun, Lance K., Muzik, Otto
Publicado em 2008

Effects of capecitabine treatment on the uptake of thymidine analogs using exploratory PET imaging agents: (18)F-FAU, (18)F-FMAU, and (18)F-FLT

Por McHugh, Christopher I., Lawhorn-Crews, Jawana M., Modi, Dipenkumar, Douglas, Kirk A., Jones, Steven K., Mangner, Thomas J., Collins, Jerry M., Shields, Anthony F.
Publicado no Cancer Imaging (2016)